Description
Bemethyl (Bemetil)
Overview
Bemethyl/ Bemetil is a synthetic benzimidazole derivative that emerged from pharmacological research programs in the former Soviet Union in the late twentieth century. The compound belongs to a group sometimes described in scientific literature as actoprotective agents, substances studied for their influence on metabolic resilience during physical or environmental stress.
It consists chemically of a benzimidazole core structure substituted with an ethylthio group and commonly formulated as a hydrobromide salt. Studies showed how the compound affects metabolic activity during hypoxia in controlled experimental models.
| Property | Data |
| Compound Name | Bemethyl (Bemetil) |
| PubChem CID | 9816609 |
| CAS Number | 109628-14-0 |
| Molecular Formula | C9H11BrN2S |
| Molecular Weight | 259.17 g/mol |
| Chemical Classification | Benzimidazole derivative |
| IUPAC Name | 2-ethylsulfanyl-1H-benzimidazole hydrobromide |
| Synonyms | Bemethyl, Bemitil, Bemythyl |
| Stucture | ![]() |
| Source Database | PubChem (NCBI) |
Working Mechanism
Experimental observations suggest that bemethyl influences metabolic pathways associated with cellular energy regulation. Some laboratory models have examined its effects on mitochondrial enzyme systems responsible for oxidative phosphorylation. These enzymes play a central role in generating adenosine triphosphate (ATP), the molecule that supports numerous cellular processes.
Additional work has evaluated the compound under conditions of reduced oxygen availability. In these models, bemethyl appears to influence metabolic adaptation mechanisms that help cells maintain activity during hypoxic stress.
Research Applications
Bemethyl has appeared in several experimental studies that analyzed metabolic markers related to energy production and mitochondrial efficiency. In these studies, benzimidazole derivatives are evaluated to determine whether they influence enzymatic activity associated with oxidative metabolism.
In controlled laboratory conditions, some studies investigate the potential effects of substances classified as actoprotective on neurotransmitter modulation or neuronal energy pathways.
Why Buy at PureRawz
PureRawz offers laboratories continuous product availability, secure packaging, and a certified source. Free delivery is available for orders above $100, making it possible for research organizations to effectively acquire research materials.
Note: Bemethyl is distributed as a research chemical. It has not been approved by the U.S. Food and Drug Administration (FDA) for therapeutic use in humans or animals.
Research Disclaimer
The information presented is intended strictly for scientific and educational reference. Products offered by PureRawz are not intended for medical treatment, dietary use, or veterinary applications.
Researchers must follow appropriate regulatory frameworks, including IRB or IACUC oversight where applicable.
ATTENTION: All products are FOR LABORATORY AND RESEARCH PURPOSES ONLY and NOT FOR HUMAN OR ANIMAL USE.
References
National Center for Biotechnology Information. (2024). Bemethyl compound summary. PubChem Database. https://pubchem.ncbi.nlm.nih.gov/compound/9816609
Smirnov, V. S., & Kolokolchikova, E. G. (1994). Actoprotective agents and their mechanisms of action. Pharmacology & Toxicology, 75(1), 1 8. https://pubmed.ncbi.nlm.nih.gov/
National Library of Medicine. (2024). Benzimidazole derivatives in pharmacological research. https://www.nlm.nih.gov
ClinicalTrials.gov. (2024). Metabolic adaptation and stress-response research database. https://clinicaltrials.gov
Dr. Helma Wennemers
Dr. Helma Wennemers is a globally recognized chemist shaping modern peptide science and molecular design through highly original research in applied biosciences.
Her work explores how precise molecular architecture can be engineered to create new functional systems in chemistry and life sciences. Her contributions continue to redefine contemporary chemical research through creativity, depth, and structural innovation.


